6 month20 on the same day, Sinopharm Engineering and Guangzhou Shuanglin Biopharmaceutical Co., Ltd. (hereinafter referred to as "Shuanglin Bio") formally signed an engineering design framework cooperation agreement. Chen Jinhui, chairman of Sinoparma Engineering, and Yan Chen, general manager of Shuanglin Biology, attended the signing ceremony, and heads of Sinoparma Engineering and Shuanglin Biology-related business sectors attended the ceremony.

This signing marks national Pharmaceutical Engineering formed a long-term strategic partnership with Shuanglin Bio in engineering design and technical services

Chen Jinhui thanked Shuanglin Bio for its long-term trust and support to the National Pharmaceutical Project. He said that this cooperation is to implement the National Pharmaceutical Group."1 4 X the layout of industrial development and the key practice of deepening the pattern of regional coordinated development. Relying on the technical capability of the whole industrial chain of pharmaceutical engineering, the National Pharmaceutical Project will provide a one-stop service covering the whole cycle of the project for Shuanglin Biology, and through the efficient allocation of professional resources, it will help Shuanglin Biology to achieve the goal of improving quality and reducing consumption, reducing costs and increasing efficiency, and jointly promote the technological upgrading of the biological products industry.

Yan Chen said that Shuanglin biology is in a period of rapid development, and a number of key projects are about to start. Sinopharm Engineering's rich experience in the field of pharmaceutical engineering and full-process technical control capabilities are the key support to ensure project quality, schedule and cost optimization. This strategic cooperation will inject strong infrastructure momentum into Shuanglin Bio's development strategy of "innovation leadership, digital empowerment and international expansion.

The strategic cooperation agreement signed, not only to further consolidate the two sides in the biomedicine and pharmaceutical engineering technology leading position, more Sinopharm group internal resource integration and ecological construction to provide replicable, can promote the successful experience, help the biopharmaceutical industry to intelligent, international direction to accelerate, and jointly create a leading industry development of the new benchmark.

(Wuhan Company Contribution)